ArTS Archivio della ricerca di Trieste

LUCAFÒ, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.675
EU - Europa 5.209
AS - Asia 4.088
SA - Sud America 579
AF - Africa 165
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.529
SG - Singapore 1.432
PL - Polonia 1.414
IT - Italia 1.332
CN - Cina 890
VN - Vietnam 489
DE - Germania 462
BR - Brasile 426
SE - Svezia 409
HK - Hong Kong 388
BD - Bangladesh 281
FR - Francia 267
FI - Finlandia 265
GB - Regno Unito 215
RU - Federazione Russa 176
KR - Corea 168
NL - Olanda 123
UA - Ucraina 121
IN - India 110
IE - Irlanda 80
TR - Turchia 77
BG - Bulgaria 71
CA - Canada 62
AR - Argentina 53
MA - Marocco 47
AT - Austria 45
BE - Belgio 44
JP - Giappone 44
MX - Messico 44
ES - Italia 31
SN - Senegal 31
ZA - Sudafrica 31
EC - Ecuador 27
SA - Arabia Saudita 26
ID - Indonesia 22
PK - Pakistan 22
IQ - Iraq 21
CO - Colombia 18
CH - Svizzera 17
PH - Filippine 17
CZ - Repubblica Ceca 14
LT - Lituania 14
CL - Cile 13
PE - Perù 13
VE - Venezuela 13
AU - Australia 12
GR - Grecia 11
RO - Romania 11
RS - Serbia 11
SI - Slovenia 11
EG - Egitto 10
MY - Malesia 10
PT - Portogallo 10
DK - Danimarca 9
DZ - Algeria 9
TH - Thailandia 9
HR - Croazia 8
JM - Giamaica 8
JO - Giordania 8
PY - Paraguay 8
TN - Tunisia 8
UZ - Uzbekistan 8
IL - Israele 7
KW - Kuwait 7
NO - Norvegia 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
IR - Iran 6
KE - Kenya 6
AL - Albania 5
HU - Ungheria 5
LB - Libano 5
MD - Moldavia 5
BO - Bolivia 4
EU - Europa 4
GT - Guatemala 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
CI - Costa d'Avorio 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
MU - Mauritius 3
NG - Nigeria 3
OM - Oman 3
QA - Qatar 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 16.703
Salva come PNG Salva come JPEG
Città #
Warsaw 1.319
Ashburn 844
Singapore 837
Fairfield 563
Chandler 451
Trieste 433
Woodbridge 428
San Jose 370
Hong Kong 368
Ann Arbor 326
Houston 303
Wilmington 253
Munich 252
Seattle 247
Beijing 197
Cambridge 175
Helsinki 174
Council Bluffs 152
Seoul 151
Ho Chi Minh City 150
Hanoi 128
Hefei 124
Jacksonville 122
Los Angeles 121
Princeton 110
Boardman 108
Dallas 102
Santa Clara 93
Chicago 92
Milan 82
Lauterbourg 80
Moscow 77
New York 75
Dublin 74
Columbus 70
Sofia 69
Rome 68
Zgierz 64
London 60
Dearborn 55
Frankfurt am Main 52
The Dalles 51
Buffalo 43
Izmir 43
Casablanca 39
São Paulo 38
Brussels 36
Dakar 31
Shanghai 31
Lappeenranta 30
Atlanta 29
Vienna 29
Dong Ket 26
Orem 26
Düsseldorf 25
San Diego 25
Guangzhou 24
Falls Church 23
Redwood City 23
Mumbai 21
Denver 20
Manchester 20
Tokyo 20
Amsterdam 19
Johannesburg 19
Nuremberg 19
Toronto 19
Brooklyn 17
Chennai 17
Redondo Beach 17
Des Moines 16
Montreal 16
Stockholm 16
Turin 16
Turku 16
Venice 16
Bremen 15
Da Nang 15
Haiphong 15
Memphis 15
Phoenix 15
Bari 14
Florence 14
Nottingham 14
Portsmouth 14
Washington 14
Bologna 13
Jeddah 13
Jinan 13
Udine 13
Wroclaw 13
Belo Horizonte 12
Charlotte 12
Nanjing 12
Naples 12
Brno 11
Guayaquil 11
Hangzhou 11
Kyiv 11
Mexico City 11
Totale 11.008
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 536
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 512
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 485
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 475
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 472
Pharmacogenetics of thiopurines 451
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 415
Pharmacogenetics of treatments for inflammatory bowel disease 381
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 375
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 330
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 324
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 313
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 309
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 306
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 302
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 288
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 286
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 270
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 265
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 265
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 255
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 251
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 251
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 240
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 238
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 237
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 236
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 230
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells 226
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 226
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 223
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 217
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 203
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 202
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 201
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 199
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 187
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 187
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 184
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 182
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 182
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa 180
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 180
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 179
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 173
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 170
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 169
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 169
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 169
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 168
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 164
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 160
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 158
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 157
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 156
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 155
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 152
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 150
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 150
Sedation and analgesia in children with cerebral palsy: a narrative review 150
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 146
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 145
Neuron-Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation 141
Microbiota and drug response in inflammatory bowel disease 141
A patent review of anticancer glucocorticoid receptor modulators (2014-present) 133
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy 126
Clinical application of thiopurine pharmacogenomics in pediatrics 122
Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications 120
Klebsiella pneumoniae contributes to altered cytotoxicity of thiopurines in vitro: Possible implications of biotransformation and bacterial metabolism 116
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress 116
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 113
NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease 113
Pharmacogenomics of antibiotics 110
Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction 101
Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients 95
Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS 77
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs 73
PIEZO1 Channels Modulate the Small Extracellular Vesicle Release in C2C12 Cells 68
Unraveling the cellular mechanisms of thiopurine-induced pancreatitis in pediatric inflammatory bowel disease: Insights from induced pluripotent stem cell models 48
Inosine-Triphosphate-Pyrophosphatase Activity as a Potential Predictor of Methotrexate Remission in Juvenile Idiopathic Arthritis 33
Totale 17.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022901 63 51 54 80 40 85 78 28 100 89 36 197
2022/20231.324 120 215 94 197 115 209 15 119 129 27 48 36
2023/2024989 48 51 37 47 87 96 180 206 31 34 111 61
2024/20252.879 43 153 234 240 215 324 243 235 367 341 222 262
2025/20266.085 577 292 385 495 510 430 822 211 732 771 550 310
2026/202711 11 0 0 0 0 0 0 0 0 0 0 0
Totale 17.163